FDA Recalls Valsartan Tablets Due to Potential Labeling Mixup
Aidapak Services, LLC is recalling Valsartan 80 mg tablets because they may have been mislabeled as other prescription drugs.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when there is a risk of significant injury or property damage, such as administering the wrong medication.
Plain-English summary
Aidapak Services, LLC is recalling Valsartan, Tablet, 80 mg, NDC 00078035834, due to a labeling mixup. The recalled product may have been mislabeled as Temazepam, Capsule, 7.5 mg; Valsartan, Tablet, 320 mg; Isosorbide Mononitrate, Tablet, 20 mg; or Cholecalciferol, Tablet.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The recall involves specific pedigree codes and expiration dates ranging from May 17, 2014, to June 21, 2014. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Patients and healthcare providers should check their medication labels against the specific pedigree codes and expiration dates listed in the official recall notice. If the medication matches the recalled product, it should be returned to the pharmacy or contact the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- VALSARTAN, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035834.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 1,440
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- VALSARTAN
- Tablet
- 80 mg has the following codes: Pedigree: AD52372_4
- EXP: 5/17/2014
- Pedigree: AD65475_10
- EXP: 5/28/2014
- Pedigree: AD68025_1
- Pedigree: AD70585_1
- EXP: 5/29/2014
- Pedigree: W002768
- EXP: 6/10/2014
- Pedigree: W003535
- EXP: 6/21/2014
- Pedigree: AD62995_4
- Pedigree: AD73597_1
- EXP: 5/31/2014
- Pedigree: W002616
- EXP: 6/4/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02